Evidence map›Paper›PMID 27324117›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.

Paola Imbrici, Concetta Altamura, Giulia Maria Camerino, Giuseppe Felice Mangiatordi, Elena Conte, Lorenzo Maggi, Raffaella Brugnoni, Kejla Musaraj, Roberta Caloiero, Domenico Alberga and 9 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Skeletal muscle ClC-1 chloride channels in health and diseases.Pflugers Archiv : European journal of physiology · 2020
    Review
  10. Pathomechanisms of aFrontiers in neurology · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Paola ImbriciDepartment of Pharmacy, Drug Sciences, University of Bari "Aldo Moro," Bari, Italy; paola.imbrici@uniba.
Concetta AltamuraDepartment of Pharmacy, Drug Sciences, University of Bari "Aldo Moro," Bari, Italy.
Giulia Maria CamerinoDepartment of Pharmacy, Drug Sciences, University of Bari "Aldo Moro," Bari, Italy.
Giuseppe Felice MangiatordiDepartment of Pharmacy, Drug Sciences, University of Bari "Aldo Moro," Bari, Italy.
Elena ConteDepartment of Pharmacy, Drug Sciences, University of Bari "Aldo Moro," Bari, Italy.
Lorenzo MaggiDivision of Neurology, Neuroimmunology and Neuromuscular Diseases Unit, Istituti di Ricovero e Cura a Carattere Scientifico Fondazione Istituto Neurologico "Carlo Besta," Milan, Italy.
Raffaella BrugnoniDivision of Neurology, Neuroimmunology and Neuromuscular Diseases Unit, Istituti di Ricovero e Cura a Carattere Scientifico Fondazione Istituto Neurologico "Carlo Besta," Milan, Italy.
Kejla MusarajDepartment of Pharmacy, Drug Sciences, University of Bari "Aldo Moro," Bari, Italy.
Roberta CaloieroDepartment of Pharmacy, Drug Sciences, University of Bari "Aldo Moro," Bari, Italy.
Domenico AlbergaDepartment of Physics "M. Merlin," Istituto Nazionale di Fisica Nucleare and Centro di Tecnologie Innovative per la Rilevazione e l'Elaborazione del Segnale, University of Bari "Aldo Moro," Bari, Italy.
Renè Massimiliano MarsanoDepartment of Biology, University of Bari "Aldo Moro," Bari, Italy.
Giulia RicciDepartment of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy.
Gabriele SicilianoDepartment of Clinical and Experimental Medicine, Section of Neurology, University of Pisa, Pisa, Italy.
Orazio NicolottiDepartment of Pharmacy, Drug Sciences, University of Bari "Aldo Moro," Bari, Italy.
Marina MoraDivision of Neurology, Neuroimmunology and Neuromuscular Diseases Unit, Istituti di Ricovero e Cura a Carattere Scientifico Fondazione Istituto Neurologico "Carlo Besta," Milan, Italy.
Pia BernasconiDivision of Neurology, Neuroimmunology and Neuromuscular Diseases Unit, Istituti di Ricovero e Cura a Carattere Scientifico Fondazione Istituto Neurologico "Carlo Besta," Milan, Italy.
Jean-Francois DesaphyDepartment of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro," Bari, Italy.
Renato MantegazzaDivision of Neurology, Neuroimmunology and Neuromuscular Diseases Unit, Istituti di Ricovero e Cura a Carattere Scientifico Fondazione Istituto Neurologico "Carlo Besta," Milan, Italy.
Diana Conte CamerinoDepartment of Pharmacy, Drug Sciences, University of Bari "Aldo Moro," Bari, Italy.
University of Bari Aldo Moro · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITUniversity of Pisa · ITIstituto Nazionale di Fisica Nucleare, Sezione di Bari · IT

Funding

Telethon GGP14096
6 · The paper itself

Abstract

Myotonia congenita is an inherited disease that is characterized by impaired muscle relaxation after contraction caused by loss-of-function mutations in the skeletal muscle ClC-1 channel. We report a novel ClC-1 mutation, T335N, that is associated with a mild phenotype in 1 patient, located in the extracellular I-J loop. The purpose of this study was to provide a solid correlation between T335N dysfunction and clinical symptoms in the affected patient as well as to offer hints for drug development. Our multidisciplinary approach includes patch-clamp electrophysiology on T335N and ClC-1 wild-type channels expressed in tsA201 cells, Western blot and quantitative PCR analyses on muscle biopsies from patient and unaffected individuals, and molecular dynamics simulations using a homology model of the ClC-1 dimer. T335N channels display reduced chloride currents as a result of gating alterations rather than altered surface expression. Molecular dynamics simulations suggest that the I-J loop might be involved in conformational changes that occur at the dimer interface, thus affecting gating. Finally, the gene expression profile of T335N carrier showed a diverse expression of K

Indexed as

ChannelopathiesChloride ChannelsElectrophysiological PhenomenaHumansIon Channel GatingMuscle, SkeletalMutationMyotonia CongenitaPatch-Clamp TechniquesPhenotypeChloride ChannelsCLC-1 channelchloride channelgene expressionmolecular dynamicspatch-clampskeletal muscle

Identifiers

PMID27324117
PMCPMC5024700
OpenAlexW2460809988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.